Inventiva ADR (IVA)

Schlusskurs vom Vortag:

$3.16

Offen:

$3.14

24-Stunden-Volumen:

24,741

Marktkapitalisierung:

$169.38M

Einnahmen:

$18.85M

Nettoeinkommen (Verlust:

$-119.67M

KGV:

-1.5996

EPS:

-2.0318

Netto-Cashflow:

$-89.09M

1W Leistung:

-2.40%

1M Leistung:

-14.02%

6M Leistung:

-10.71%

1J Leistung:

+34.02%

1-Tages-Spanne:

$3.06

$3.275

52-Wochen-Spanne:

$2.40

$5.05

Inventiva ADR Stock (IVA) Company Profile

Firmenname

Inventiva ADR

Sektor

Healthcare (1191)

Branche

Biotechnology (688)

Telefon

33 3 80 44 75 00

Adresse

50 rue de Dijon, Daix

Mitarbeiter

84

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

IVA's Discussions on Twitter

Inventiva ADR Stock (IVA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-10-27	Eingeleitet	Canaccord Genuity	Buy
2023-05-31	Eingeleitet	ROTH MKM	Buy
2023-05-19	Hochstufung	Societe Generale	Sell → Buy
2023-03-17	Eingeleitet	Stifel	Buy
2022-11-15	Herabstufung	Societe Generale	Buy → Sell
2021-03-08	Herabstufung	Societe Generale	Buy → Sell
2020-08-05	Eingeleitet	ROTH Capital	Buy
2020-08-04	Eingeleitet	Guggenheim	Buy
2020-08-04	Eingeleitet	Stifel	Buy

Alle ansehen

Inventiva ADR Aktie (IVA) Neueste Nachrichten

Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2023 et de son Rapport Annuel 2023 (« Form 20-F »)

GlobeNewswire Inc.

Inventiva annonce la nomination d’Andre Turenne en tant qu’administrateur

GlobeNewswire Inc.

Inventiva publie ses résultats annuels 2023

GlobeNewswire Inc.

Inventiva announces the schedule of publication and presentation of its 2023 Full-Year Financial Results

GlobeNewswire Inc.

Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with MASH/NASH and T2D

GlobeNewswire Inc.

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

The Motley Fool

Finanzdaten der Inventiva ADR-Aktie (IVA)

Inventiva ADR (IVA) Umsatz 2024

Inventiva ADR (IVA) Nettogewinn 2024

Inventiva ADR (IVA) Free Cashflow 2024

Inventiva ADR (IVA) Gewinn je Aktie 2024